日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

A case of non-neutropenic invasive pulmonary aspergillosis under immune checkpoint inhibitor therapy for malignant melanoma

一例接受免疫检查点抑制剂治疗恶性黑色素瘤的患者发生非中性粒细胞减少性侵袭性肺曲霉病的病例报告

期刊:Respiratory Medicine Case Reports
影响因子:0.7
doi:10.1016/j.rmcr.2022.101627
Uchida, Yoshinori; Shimamura, So; Ide, Shuichiro; Masuda, Kazuki; Saiki, Masafumi; Sogami, Yusuke; Ishihara, Hiroshi
黑色素瘤
中性粒细胞
粒细胞
细胞生物学
免疫/内分泌
发表日期：2022
文献求助 收藏

Dramatic response to alectinib in an ALK-positive LCNEC patient with a poor performance status: A case report

ALK阳性大细胞神经内分泌癌患者（一般状况较差）对阿来替尼治疗反应显著：病例报告

期刊:Respirology Case Reports
影响因子:0.8
doi:10.1002/rcr2.817
Masuda, Kazuki; Saiki, Masafumi; Shimamura, So; Ide, Shuichiro; Uchida, Yoshinori; Sogami, Yusuke; Ishihara, Hiroshi; Ikeda, Fumi; Kugiyama, Kiyotaka
ALK
细胞生物学
肿瘤
肿瘤免疫
发表日期：2021
文献求助 收藏

Significant therapeutic effectiveness of durvalumab after chemoradiotherapy for a patient with post-operative recurrent pulmonary pleomorphic carcinoma

度伐利尤单抗在接受放化疗后治疗术后复发性肺多形性癌患者中显示出显著的治疗效果

期刊:Respirology Case Reports
影响因子:0.8
doi:10.1002/rcr2.781
Shimamura, So; Saiki, Masafumi; Ide, Shuichiro; Masuda, Kazuki; Uchida, Yoshinori; Sogami, Yusuke; Kasai, Kazunari; Inoue, Tomohiro; Ishihara, Hiroshi
肿瘤
肿瘤免疫
发表日期：2021
文献求助 收藏

Myositis induced by durvalumab in a patient with non-small cell lung cancer: A case report

度伐利尤单抗诱发非小细胞肺癌患者肌炎：病例报告

期刊:Thoracic Cancer
影响因子:2.3
doi:10.1111/1759-7714.13709
Kobayashi, Miyuki; Saiki, Masafumi; Omori, Chisa; Ide, Shuichiro; Masuda, Kazuki; Sogami, Yusuke; Hata, Takanori; Ishihara, Hiroshi
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2020
文献求助 收藏

Analysis of significantly mutated genes as a clinical tool for the diagnosis in a case of lung cancer.

显著突变基因分析作为肺癌诊断的临床工具

期刊:Respiratory Medicine Case Reports
影响因子:0.7
doi:10.1016/j.rmcr.2017.02.008
Miyashita Yoshihiro, Hirotsu Yosuke, Tsutsui Toshiharu, Higashi Seishi, Sogami Yusuke, Kakizaki Yumiko, Goto Taichiro, Amemiya Kenji, Oyama Toshio, Omata Masao
肿瘤
肿瘤免疫
发表日期：2017
文献求助 收藏